Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
7 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Phase 2 trial of hypoxia activated evofosfamide (TH302) for treatment of recurrent bevacizumab-refractory glioblastoma.
Sci Rep. 2021 Jan 27;11(1):2306. doi: 10.1038/s41598-021-81841-0.
Sci Rep. 2021.
PMID: 33504881
Free PMC article.
Clinical Trial.
Hypoxia-activated evofosfamide for treatment of recurrent bevacizumab-refractory glioblastoma: a phase I surgical study.
Brenner A, Zuniga R, Sun JD, Floyd J, Hart CP, Kroll S, Fichtel L, Cavazos D, Caflisch L, Gruslova A, Huang S, Liu Y, Lodi A, Tiziani S.
Brenner A, et al. Among authors: fichtel l.
Neuro Oncol. 2018 Aug 2;20(9):1231-1239. doi: 10.1093/neuonc/noy015.
Neuro Oncol. 2018.
PMID: 29415215
Free PMC article.
Clinical Trial.
Item in Clipboard
Safety, pharmacokinetics, and antitumor response of depatuxizumab mafodotin as monotherapy or in combination with temozolomide in patients with glioblastoma.
Gan HK, Reardon DA, Lassman AB, Merrell R, van den Bent M, Butowski N, Lwin Z, Wheeler H, Fichtel L, Scott AM, Gomez EJ, Fischer J, Mandich H, Xiong H, Lee HJ, Munasinghe WP, Roberts-Rapp LA, Ansell PJ, Holen KD, Kumthekar P.
Gan HK, et al. Among authors: fichtel l.
Neuro Oncol. 2018 May 18;20(6):838-847. doi: 10.1093/neuonc/nox202.
Neuro Oncol. 2018.
PMID: 29077941
Free PMC article.
Clinical Trial.
Item in Clipboard
Efficacy and safety results of ABT-414 in combination with radiation and temozolomide in newly diagnosed glioblastoma.
Reardon DA, Lassman AB, van den Bent M, Kumthekar P, Merrell R, Scott AM, Fichtel L, Sulman EP, Gomez E, Fischer J, Lee HJ, Munasinghe W, Xiong H, Mandich H, Roberts-Rapp L, Ansell P, Holen KD, Gan HK.
Reardon DA, et al. Among authors: fichtel l.
Neuro Oncol. 2017 Jul 1;19(7):965-975. doi: 10.1093/neuonc/now257.
Neuro Oncol. 2017.
PMID: 28039367
Free PMC article.
Clinical Trial.
Item in Clipboard
Phase 2 study of CT-322, a targeted biologic inhibitor of VEGFR-2 based on a domain of human fibronectin, in recurrent glioblastoma.
Schiff D, Kesari S, de Groot J, Mikkelsen T, Drappatz J, Coyle T, Fichtel L, Silver B, Walters I, Reardon D.
Schiff D, et al. Among authors: fichtel l.
Invest New Drugs. 2015 Feb;33(1):247-53. doi: 10.1007/s10637-014-0186-2. Epub 2014 Nov 13.
Invest New Drugs. 2015.
PMID: 25388940
Clinical Trial.
Item in Clipboard
Genotypic and allelic frequencies of SULT1A1 polymorphisms in women receiving adjuvant tamoxifen therapy.
Grabinski JL, Smith LS, Chisholm GB, Drengler R, Rodriguez GI, Lang AS, Kalter SP, Garner AM, Fichtel LM, Hollsten J, Pollock BH, Kuhn JG.
Grabinski JL, et al. Among authors: fichtel lm.
Breast Cancer Res Treat. 2006 Jan;95(1):13-6. doi: 10.1007/s10549-005-9019-5.
Breast Cancer Res Treat. 2006.
PMID: 16317586
Item in Clipboard
Liver transplant-associated graft-versus-host disease.
Smith DM, Agura E, Netto G, Collins R, Levy M, Goldstein R, Christensen L, Baker J, Altrabulsi B, Osowski L, McCormack J, Fichtel L, Dawson DB, Domiati-Saad R, Stone M, Klintmalm G.
Smith DM, et al. Among authors: fichtel l.
Transplantation. 2003 Jan 15;75(1):118-26. doi: 10.1097/00007890-200301150-00022.
Transplantation. 2003.
PMID: 12544883
Item in Clipboard
Cite
Cite